Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction: An International, Multicenter, Randomized, Placebo-Controlled Trial

✍ Scribed by James E. Udelson; Cesare Orlandi; John Ouyang; Holly Krasa; Christopher A. Zimmer; Geir Frivold; W. Herbert Haught; Sheiba Meymandi; Cezar Macarie; Dimitar Raef; Patricia Wedge; Marvin A. Konstam; Mihai Gheorghiade

• Book ID: 119267778
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 561 KB
• Volume: 52
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/j.jacc.2008.08.013